Bicyclo[2.2.1]heptane, 2-ethyl-5-methoxy-
Common Name: |
Bicyclo[2.2.1]heptane, 2-ethyl-5-methoxy- |
IUPAC Name: |
2-ethyl-5-methoxybicyclo[2.2.1]heptane |
Molecular Formula: |
C6H12OS |
SMILES: |
CCC1CC2CC1CC2OC |
Inchi: |
1S/C10H18O/c1-3-7-4-9-5-8(7)6-10(9)11-2/h7-10H,3-6H2,1-2H3 |
Inchi Key: |
UNUPWPQAAUTOII-UHFFFAOYSA-N |
Cas No: |
122795-41-9 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
2 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
132.22 |
Mass (g/mol) |
154.136 |
Molar Refractivity |
39.09 |
Net Charge |
|
HBD |
|
HBA |
1 |
Rt Bonds |
2 |
Rings |
2 |
TPSA |
55.87 |
Hetero Atoms |
1 |
Heavy Atoms |
8 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
194.00 to 196.00 |
Vapor Pressure (mmHg@25.00 °C) |
0.585 |
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.83 |
LogP |
2.458 |
iLOGP |
1.85 |
XLOGP3 |
1.63 |
WLOGP |
1.53 |
MLOGP |
1.39 |
ESOL Log S |
-1.55 |
ESOL Solubility (mg/ml) |
3.69 |
ESOL Solubility (mol/l) |
0.028 |
ESOL Class: esol_class |
Very soluble |
Ali Log S |
-2.42 |
Ali Solubility (mg/ml) |
0.51 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Soluble |
Silicos-IT LogSw |
-1.16 |
Silicos-IT Solubility (mg/ml) |
9.08 |
Silicos-IT Solubility (mol/l) |
0.07 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.95 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
1.083 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.936 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |